SM
ABBV icon

Scoggin Management’s AbbVie ABBV Stock Holding History

Scoggin Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-199,100
Closed -$10.5M – 88
2013
Q4 		$10.5M Buy
+199,100
New +$9.79M 0.88% 36

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Scoggin Management's ABBV Position: Q3 2015 in Review

Scoggin Management sold out of AbbVie (ABBV) in Q3 2015, closing a stake of 393,000 shares — an estimated $26.4M sold.

Scoggin Management first reported a position in ABBV in Q4 2013 and held it in 7 quarters. The position peaked at $37.6M in Q2 2014. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

  • Scoggin Management reported no remaining AbbVie position as of Q3 2015 after selling out during the quarter.
  • Scoggin Management sold 393,000 AbbVie shares in Q3 2015, an estimated $26.4M.
  • Scoggin Management first reported a position in AbbVie in Q4 2013 and held it in 7 quarters.
  • Scoggin Management's AbbVie position peaked at $37.6M in Q2 2014.
  • 1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Scoggin Management's 13F filing for Q3 2015, filed 13 Nov 2015.